Federal contractor profile
CSL BEHRING L.L.C.
UEI H3WKVE9VBLY3CAGE 07PZ8
Overview
- Legal name
- CSL BEHRING L.L.C.
- Also known as
- CSL BEHRING LLC
- Registered location
- KING OF PRUSSIA, PA, USA
- Primary NAICS
- 325412 — Pharmaceutical Preparation Manufacturing
- Latest award activity
- Sep 11, 2026
Read company summary
CSL BEHRING L.L.C. is associated with UEI H3WKVE9VBLY3 and CAGE 07PZ8 in public federal records. AcornBids currently links 7 prime awards totaling $779.6K in obligations to this entity. Its largest recorded federal customer by obligations is Department of Veterans Affairs. Its recorded federal awards include work classified as Pharmaceutical Preparation Manufacturing. These categories describe the loaded award records, not a complete list of company capabilities. Its primary SAM.gov NAICS is 325412 (Pharmaceutical Preparation Manufacturing). Its public SAM.gov registration lists KING OF PRUSSIA, PA, USA.
At a glance
Prime contract obligations across loaded award records. Obligations are not revenue or contract ceilings. Summary updated Oct 19, 2026. Refresh pending; these totals may be out of date.
Business information
Public SAM.gov registration details.
- Legal name
- CSL BEHRING L.L.C.
- Doing business as
- CSL BEHRING LLC
- UEI
- H3WKVE9VBLY3
- CAGE
- 07PZ8
- Registered address
- 1020 1ST AVE, KING OF PRUSSIA, PA, 19406, USA
- Registration status
- Active
- Primary NAICS
- 325412 — Pharmaceutical Preparation Manufacturing
- SAM activation
- Dec 2, 2025
- Initial registration
- Mar 4, 2002
- Entity start
- Jan 1, 1995
- SAM updated
- Dec 2, 2025
- Registration expires
- Dec 2, 2026
- Fiscal year end
- Jun 30
- Place of incorporation
- DE, USA
Research brief
Source facts
- Loaded prime-award records link 7 awards and $779,569 in reported obligations to this legal entity. Source
- Recorded awards include Pharmaceutical Preparation Manufacturing (NAICS 325412); this classification is not proof of every company capability. Source
- An example award describes: ANDEMBRY (GARADACIMAB-GXII) 200MG/1.2ML AUTO INJECTOR Source
Federal award analysis
Net transaction obligations by federal fiscal period.
Reported transaction obligations by federal fiscal period; includes deobligations. Missing transactions are not estimated. Histories follow awards currently assigned to this recipient and may include transactions under an earlier recipient. Coverage: 7 of 7 selected awards. Select a period to explore its awards.
Funding change
Dated, valued transaction obligations in equal-length adjacent periods; missing records are unknown. Default: last completed federal fiscal year. Percentage is unavailable when the prior period has no positive reported obligations.
| Measure | Reported value |
|---|---|
| Current period | Oct 1, 2025 – Sep 30, 2026 |
| Current obligations | $663.0K |
| Prior period | Oct 1, 2024 – Sep 30, 2025 |
| Prior obligations | $-19.6K |
| Change | $682.7K |
| Growth | Not comparable |
Where the work is performed
State tile map; darker tiles have larger absolute net obligations. Outlined tiles indicate net deobligations. Unshaded tiles have no reported transactions in this selection. Other locations appear in the table.
Agencies
| Category | Period obligations | Awards |
|---|---|---|
| Department of Veterans Affairs | $643.4K | 7 |
Offices
| Category | Period obligations | Awards |
|---|---|---|
| 248-NETWORK CONTRACT OFFICE 8 (36C248) | $492.0K | 4 |
| 252-NETWORK CONTRACT OFFICE 12 (36C252) | $171.0K | 2 |
| 247-NETWORK CONTRACT OFFICE 7 (36C247) | $-19.6K | 1 |
Naics
| Category | Period obligations | Awards |
|---|---|---|
| 325412 — Pharmaceutical Preparation Manufacturing | $643.4K | 7 |
Psc
| Category | Period obligations | Awards |
|---|---|---|
| 6505 — Drugs and Biologicals | $663.0K | 6 |
| Q517 — Pharmacy Services | $-19.6K | 1 |
Vehicles
| Category | Period obligations | Awards |
|---|---|---|
| 36F79721D0249 | $643.4K | 7 |
Set Asides
| Category | Period obligations | Awards |
|---|---|---|
| Unclassified | $643.4K | 7 |
Recent federal awards
Prime contract awards. Select an award to review its history and source evidence.
| Award / description | Awarding agency | Obligations | Start date | End date |
|---|---|---|---|---|
| 36C25226F0447ANDEMBRY (GARADACIMAB-GXII) 200MG/1.2ML AUTO INJECTOR | Department of Veterans Affairs | $85.5K | Sep 11, 2026 | Sep 30, 2026 |
| 36C24826F0207C1 INHIBITOR (HUMAN) 3000 UNITS/VIL INJ,SOLN HAEGARDA | Department of Veterans Affairs | $183.9K | Jul 29, 2026 | Jul 31, 2026 |
| 36C24826F0187HAERGHA | Department of Veterans Affairs | $36.8K | Jul 1, 2026 | Jul 31, 2026 |
| 36C25226F0318ANDEMBRY (GARADACIMAB-GXII) 200MG/1.2ML AUTO INJECTOR | Department of Veterans Affairs | $85.5K | Jun 23, 2026 | Jul 18, 2026 |
| 36C24826F0091C1 INHIBITOR (HUMAN) | Department of Veterans Affairs | $147.1K | Feb 27, 2026 | Mar 27, 2026 |
| 36C24826F0037EMERGENCY HAEGARDA C1 INHIBITOR | Department of Veterans Affairs | $124.2K | Oct 22, 2025 | Nov 22, 2025 |
| 36C24724F0143HAEGARDA INJECTIONS | Department of Veterans Affairs | $116.6K | Jan 1, 2024 | Nov 27, 2024 |
Registration, certifications & contacts
| Registration evidence | Date |
|---|---|
| SAM updated | Dec 2, 2025 |
| Source loaded | Sep 26, 2026 |
| Initial registration | Mar 4, 2002 |
| Entity start | Jan 1, 1995 |
| Industry | Reported size status |
|---|---|
| 325412 — Pharmaceutical Preparation Manufacturing | Not reported |
| Contact | Role | Published contact methods | Evidence | Source date |
|---|---|---|---|---|
| MADONNA JARRETT | Government business | Contact method not published | SAM registration | Not available |
| STEPHANIE L KUPSKI | Alternate government business | Contact method not published | SAM registration | Not available |
| JOHN BUNN | Electronic business | Contact method not published | SAM registration | Not available |
| JIGISHA PAREKH | Alternate electronic business | Contact method not published | SAM registration | Not available |
Registered industries
- 325412 — Pharmaceutical Preparation Manufacturing
Registration classifications and published certificates do not by themselves establish eligibility for a particular solicitation. View SAM source
Related companies worth researching
Explore the customer, work and award-size evidence behind each match.
Data coverage and methodology
Sources: SAM.gov registration, USAspending awards and transactions, and linked supporting records. Prime contract obligations, IDV ceilings and assistance amounts are kept separate. Missing records are not zero activity. Company claims are labeled separately. Recompete signals are rule-based scores out of 100. Positioning windows are AcornBids estimates.
Disclosed relationships only. Missing records do not establish that a contractor has no partners. Ambiguous parent award identifiers are excluded.
Recently viewed companies
Keep your research moving
Save this company, track changes, and evaluate upcoming work against your targets.
Save to my research Find my fit